MX2007004376A - Composiciones de fosfolipido y farmaco anti inflamatorio no esteroide asociados, y metodos para prepararlos. - Google Patents

Composiciones de fosfolipido y farmaco anti inflamatorio no esteroide asociados, y metodos para prepararlos.

Info

Publication number
MX2007004376A
MX2007004376A MX2007004376A MX2007004376A MX2007004376A MX 2007004376 A MX2007004376 A MX 2007004376A MX 2007004376 A MX2007004376 A MX 2007004376A MX 2007004376 A MX2007004376 A MX 2007004376A MX 2007004376 A MX2007004376 A MX 2007004376A
Authority
MX
Mexico
Prior art keywords
methods
same
inflammatory drug
preparing
steroidal anti
Prior art date
Application number
MX2007004376A
Other languages
English (en)
Inventor
Lenard M Lichtenberger
Original Assignee
Stem The Board Of Regents Of The University Of Texas Sy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stem The Board Of Regents Of The University Of Texas Sy filed Critical Stem The Board Of Regents Of The University Of Texas Sy
Publication of MX2007004376A publication Critical patent/MX2007004376A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describe una nueva composicion farmaceutica que contiene un complejo purificado de fosfolipido y farmaco anti inflamatorio no esteroide selectivo y/o no selectivo asociados, y metodos para elaborarlo y usarlo. Tambien se describe un metodo de deteccion selectiva para identificar compuestos que forman complejos asociados con fosfolipidos.
MX2007004376A 2004-10-12 2005-10-12 Composiciones de fosfolipido y farmaco anti inflamatorio no esteroide asociados, y metodos para prepararlos. MX2007004376A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61773204P 2004-10-12 2004-10-12
US68244005P 2005-05-19 2005-05-19
PCT/US2005/036519 WO2006044377A2 (en) 2004-10-12 2005-10-12 Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same

Publications (1)

Publication Number Publication Date
MX2007004376A true MX2007004376A (es) 2007-06-19

Family

ID=36203456

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007004376A MX2007004376A (es) 2004-10-12 2005-10-12 Composiciones de fosfolipido y farmaco anti inflamatorio no esteroide asociados, y metodos para prepararlos.

Country Status (10)

Country Link
US (1) US8802656B2 (es)
EP (1) EP1804766A2 (es)
JP (1) JP2008515977A (es)
KR (1) KR20070063587A (es)
AU (1) AU2005295874B2 (es)
CA (1) CA2584505A1 (es)
IL (1) IL182505A0 (es)
MX (1) MX2007004376A (es)
SG (1) SG156633A1 (es)
WO (1) WO2006044377A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080051373A1 (en) * 2003-07-31 2008-02-28 The Board Of Regents Of The University Of Texas System Parenteral preparations of GI-safer phospholipid-associated anti-inflammatories and methods of preparation and use
KR20090034385A (ko) * 2006-07-19 2009-04-07 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 염증성 장질환을 치료하기 위한 5-아미노살리실산 함유 약제 및 인지질의 제제
EP2068833B1 (en) * 2006-07-26 2013-01-09 The Board of Regents of the University of Texas System Parenteral preparations of gi-safer phospholipid-associated anti-inflammatories and methods of preparation and use
ITMI20061883A1 (it) * 2006-09-29 2008-03-30 Monteres S R L Formulazioni orodispersibili, gastroprotettive e taste- masking contenenti almeno un principio attivo gastrolesivo
JP5963198B2 (ja) * 2012-09-26 2016-08-03 国立研究開発法人科学技術振興機構 動的ネットワークバイオマーカーの検出装置、検出方法及び検出プログラム
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
RU2717247C2 (ru) * 2017-11-01 2020-03-19 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермская государственная фармацевтическая академия" Министерства здравоохранения Российской Федерации (ПГФА) Способ отбора противовоспалительных средств в ряду производных антраниловой кислоты с использованием расчетных констант липофильности и ионизации
WO2020094736A1 (en) 2018-11-07 2020-05-14 Sapir Pharmaceuticals Inc. Lipidic solutions of nsaids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
US5763422A (en) * 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US6656498B1 (en) 1998-11-25 2003-12-02 Vanderbilt University Cationic liposomes for gene transfer
JP4958381B2 (ja) * 2000-12-19 2012-06-20 ザ・ボード・オブ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・テキサス・システム 胃腸管保護および治療活性増強のためのレシチン油およびnsaidsの製剤を用いる方法および組成物

Also Published As

Publication number Publication date
EP1804766A2 (en) 2007-07-11
WO2006044377A2 (en) 2006-04-27
SG156633A1 (en) 2009-11-26
AU2005295874B2 (en) 2011-01-27
WO2006044377A3 (en) 2006-08-31
JP2008515977A (ja) 2008-05-15
IL182505A0 (en) 2007-09-20
AU2005295874A1 (en) 2006-04-27
KR20070063587A (ko) 2007-06-19
CA2584505A1 (en) 2006-04-27
US8802656B2 (en) 2014-08-12
US20060078574A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
MX2007004376A (es) Composiciones de fosfolipido y farmaco anti inflamatorio no esteroide asociados, y metodos para prepararlos.
CY1116373T1 (el) Φαρμακευτικα σκευασματα που περιεχουν μεθυλναλτρεξονη
BRPI0415288A (pt) composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
IL179140A (en) Mixture of antibody-drug conjugate, a cancer drug for its cancer treatment, and a method for preparing the mixture
MXPA05013977A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
AR053412A1 (es) Compuestos inhibidores de la interaccion entre mdm2 y p53, un metodo de preparadcion, composicion farmaceutica y uso del compuesto para fabricar medicamentos
MX2007006743A (es) Ligandos del receptor de acetilcolina nicotinica.
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
SE9901875D0 (sv) Novel compounds
MX2007006387A (es) Derivados de piridina 3-substituidos como antagonistas h3.
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
DE602005022613D1 (en) 2,3,4-substituierte cyclopentanone als therapeutische mittel
MY150497A (en) New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
ATE528301T1 (de) Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
TR200100895T2 (tr) Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı
WO2005033113A3 (en) Indole derivatives
WO2005081972A3 (en) Maleiimide anti-tumor phosphatase inhibitors
DE60226313D1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
IN2014DN04587A (es)
MX2007007024A (es) Ligandos del receptor acetilcolina nicotinica.
FR2842526B1 (fr) Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-indole, procede de preparation a titre de medicaments
ATE392213T1 (de) Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen
ATE344800T1 (de) Substituierte [1,4öbenzodioxin[2,3-eöisoindol- derivaten, ihr verfahren zur herstellung und ihre pharmazeutische zusammensetzungen
ZA200302392B (en) Indoline compounds, a process for their preparation and pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
FG Grant or registration